news
Kymab on Sunday Times Tech Track ‘Ones to Watch’ list
7 September 2015 | By Victoria White
The ranking recognises Kymab’s potential for rapid future sales growth and increasing international presence...
List view / Grid view
Malaria
news
Anti-malaria drugs could be a potential treatment for Parkinson’s disease
17 July 2015 | By Victoria White
Scientists have found that existing anti-malaria drugs, Chloroquine and Amodiaquine, could be a potential treatment for Parkinson's disease...
news
The Francis Crick Institute and GSK join forces to forge new scientific discoveries
14 July 2015 | By Victoria White
The Francis Crick Institute and GSK are to partner up to explore new avenues of medical research and drug discovery across a broad range of diseases...
news
Scientists identify a new way to kill the malaria parasite
7 July 2015 | By Victoria White
Scientists have discovered new ways in which the malaria parasite survives in the blood stream of its victims, a discovery that could lead to new treatments...
news
Researchers programme solitary yeast cells to talk to one another
1 July 2015 | By Victoria White
A team researchers has engineered yeast cells (Saccharomyces cerevisiae) that can "talk" to one another, using a versatile plant hormone called auxin...
news
New target may increase odds of successful mosquito-based malaria vaccine
16 June 2015 | By Victoria White
Researchers from the Johns Hopkins Bloomberg School of Public Health have located a new target for a potential vaccine against malaria...
news
Anti-Ebola MVA vaccine produced on ProBioGen’s AGE1.CR cell line platform enters clinical trials
3 June 2015 | By Victoria White
An investigational vaccine against Ebola, produced on ProBioGen’s proprietary, continuous muscovy duck AGE1.CR cell line, has proceeded into clinical trials...
news
New therapeutic target for colorectal cancer has been identified
28 April 2015 | By Victoria White
Researchers at the Institut Hospital del Mar d’Investigacions Mèdiques (IMIM) have identified a new way of treating colorectal cancer...
news
Merck Serono and Medicines for Malaria Venture sign agreement to develop potential antimalarial therapy
2 April 2015 | By Victoria White
Merck Serono and MMV have announced that an agreement has been signed for Merck Serono to obtain the rights to the antimalarial compound DDD107498...
news
A vaccine against placental malaria made with ExpreS2ion Biotechnologies’ protein expression technology, ExpreS2, is ready to start human tests in Germany and Benin
20 March 2015 | By Victoria White
ExpreS2ion Biotechnologies announce the release by its partners at University of Copenhagen of a vaccine against placental malaria for testing in humans...
news
Kymab strengthens and expands capabilities through Board appointments and Executive promotions
29 September 2014 | By Kymab
Following a US$40 million Series B investment from The Wellcome Trust and the Bill & Melinda Gates Foundation...
news
GSK and MMV announce start of phase III programme of tafenoquine for Plasmodium vivax malaria
28 April 2014 | By GlaxoSmithKline
GlaxoSmithKline and Medicines for Malaria Venture announced the start of a phase III global programme to evaluate the efficacy and safety of tafenoquine...
